Hauptman-Woodward Medical Research Institute

Last updated
Hauptman-Woodward Medical Research Institute
AbbreviationHWI
Formation1956
FounderDr. George F. Koepf, Helen Woodward Rivas
Type Non-profit
Location
Key people
Edward H. Snell (CEO)
Andrew M. Gulick (VP for Research)
Staff
75 (approx.)
Website http://www.hwi.buffalo.edu/
Formerly called
Medical Foundation of Buffalo

The Hauptman-Woodward Medical Research Institute (HWI) is an independent, not-for-profit, biomedical research facility located in the Buffalo Niagara Medical Campus affiliated with the University at Buffalo. Its focus is on structural biology with a strong history in methods development and the application of X-ray crystallography in fundamental studies.[ citation needed ]

Contents

Medical research

HWI scientists work to find the fundamental causes of many diseases. For example, cancer is being attacked by identifying new classes of anti-tumor agents including new inhibitors for hormone-dependent breast tumors. Other projects include:

HWI scientists use a methodology known as structural biology, which allows them to create 3D models of the molecules that build up cells. The investigation results provide many insights into how these molecular machines work, including the starting points for the design of better drugs. HWI is also focused to developing highly trained researchers and in its role as the Department of Structural and Computational Biology for the University at Buffalo, the Institute typically trains about a dozen PhD students and sponsors internship programs for high school and college students. [1]

History

The Hauptman-Woodward Medical Research Institute was founded in 1956 as the "Medical Foundation of Buffalo" and came into existence through the combined efforts of Dr. George F. Koepf, who provided the vision, and Helen Woodward Rivas, who provided generous financial support. Koepf was a physician and endocrinologist whose interest in research began during his second year at medical school and continued at Johns Hopkins University. After leaving Johns Hopkins, he returned to practice medicine in Buffalo and became a founding member of the Buffalo Medical Group. One of his patients, Helen Woodward Rivas, expressed great interest in funding a medical research effort in Buffalo. Through her $3 million (equivalent to $29,901,000in 2021) gift, the Medical Foundation (MFB) came into being.

Herbert Hauptman at University of Buffalo graduation in 2009 Herbert Hauptman - UB 2009.jpg
Herbert Hauptman at University of Buffalo graduation in 2009

An example of the basic research carried out includes studying disease processes at the molecular scale. For example it was reported [2] that a researcher at the Hauptman-Woodward Medical Research Institute had moved a step closer to a cure, and possibly the prevention, of the most common type of breast cancer.

In 1994, the Medical Foundation was renamed the Hauptman-Woodward Medical Research Institute. The name "Hauptman" comes from Herbert A. Hauptman, who pioneered mathematical techniques for determining atomic structure from X-ray diffraction. For this discovery, Hauptman and Jerome Karle were awarded the Nobel prize in chemistry in 1985.

In 1999, the Institute received a three-year $1.5 million (equivalent to $2,440,000in 2021) challenge grant from the John R. Oishei Foundation along with a $750,000 (equivalent to $1,220,000in 2021) award from the Margaret L. Wendt Foundation that established a Structural Biology Center at HWI. All aspects of structural research from isolating the gene that codes for a protein of interest to applying the latest crystallographic methods are now possible here. Through this Center, HWI scientists were able to create new and improved crystal growth methods including the development of a novel and patented high-throughput robotic crystallization technique for expediting and optimizing the crystallization process. [3]

In 2001, BWI became a founding partner of the Buffalo Niagara Medical Campus "BNMC," and created the University at Buffalo Department of Structural Biology. Dr. George DeTitta was appointed Executive Director and CEO and Dr. Walter Pangborn was appointed to Executive Vice President. Shortly thereafter, four new scientists were added. As the University at Buffalo and Roswell Park Comprehensive Cancer Center, both members of BNMC, began plans to construct new facilities, HWI joined to form the Buffalo Life Sciences Complex which is located in the heart of the BNMC adjacent to the UB and Roswell Park sites. CannonDesign was retained along with architect Mehrdad Yazdani to design a research and office complex and construction of the Structural Biology Research Center began in August 2003, through the support of New York State, the Federal Government, local foundations, community leaders, and individuals, as well as financing through KeyBank. BWI moved into the new facility in April 2005, and have since recruited four additional scientists to the facility. [3]

Leadership

On April 1, 2008, George DeTitta stepped down as CEO to return to full-time work in the lab and on July 1, 2008, Eaton E. (Ed) Lattman, formerly a Professor of Biophysics at Johns Hopkins University became HWI's new CEO. Ed was previously the Dean of Research and Graduate Education at Hopkins. [3]

On December 1, 2014, Dr. Edward H. Snell was appointed CEO following eight years of service to HWI as a Senior Research Scientist. Before joining HWI, Dr. Snell was a staff scientist in NASA’s Structural Biology Laboratory at the Marshall Space Flight Center in Huntsville, Alabama. [3]

Awards

The institute has sponsored the award "Pioneer of Science". [4] It also runs a popular annual wine tasting event where Riedel glassware is coupled with quality wines and champagne and the influence of the shape of the glass on the taste demonstrated. The link between the glass, wine and research, comes from the use of crystals in the research and the rich information they supply when examined in detail.

See also

Related Research Articles

<span class="mw-page-title-main">University at Buffalo</span> Public university in Buffalo, New York

The State University of New York at Buffalo, commonly called the University at Buffalo (UB) and sometimes called SUNY Buffalo, is a public research university with campuses in Buffalo and Amherst, New York. The university was founded in 1846 as a private medical college and merged with the State University of New York system in 1962. It is one of the two flagship institutions of the SUNY system. As of fall 2020, the university enrolled 32,347 students in 13 schools and colleges, making it the largest and most comprehensive public university in the state of New York.

<span class="mw-page-title-main">Herbert A. Hauptman</span> American mathematician

Herbert Aaron Hauptman was an American mathematician and Nobel laureate. He pioneered and developed a mathematical method that has changed the whole field of chemistry and opened a new era in research in determination of molecular structures of crystallized materials. Today, Hauptman's direct methods, which he continued to improve and refine, are routinely used to solve complicated structures. It was the application of this mathematical method to a wide variety of chemical structures that led the Royal Swedish Academy of Sciences to name Hauptman and Jerome Karle recipients of the 1985 Nobel Prize in Chemistry.

<span class="mw-page-title-main">Roswell Park Comprehensive Cancer Center</span> Hospital in New York, United States

Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".

<span class="mw-page-title-main">Buffalo Niagara Medical Campus</span>

The Buffalo Niagara Medical Campus (BNMC) is a medical center of health care, life sciences research and medical education institutions, co-located on 120 acres (49 ha) in Buffalo, New York. The BNMC was founded in 2001 by a consortium. This project comprises one of the five "Strategic Investment Areas" that make up Buffalo, NY's Queen City Hub Plan, the city's strategic plan for urban redevelopment.

<span class="mw-page-title-main">Ludwig Cancer Research</span>

Ludwig Cancer Research is an international community of scientists focused on cancer research, with the goal of preventing and controlling cancer. It encompasses the Ludwig Institute for Cancer Research, an international non-profit organization founded in 1971 by philanthropist Daniel K. Ludwig. The Institute is headquartered in New York City, with a European office located in Zurich. In addition, six Ludwig Centers were established at leading US cancer research institutions. Together, the Institute and Centers are known as Ludwig Cancer Research.

Jeremy Maurice Jacobs Sr. is an American billionaire businessman, the owner of the Boston Bruins and chairman of Delaware North. Forbes magazine ranks him as 481st richest person in the world.

<span class="mw-page-title-main">H. Lee Moffitt Cancer Center & Research Institute</span> Hospital in Florida, United States

Houston Lee Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.

HWI may refer to:

Dennis Joseph Slamon, is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25-33% of breast cancer patients and the resulting treatment trastuzumab.

<span class="mw-page-title-main">King Hussein Cancer Center</span> Hospital in Amman, Jordan

The King Hussein Cancer Center (KHCC), is a Cancer hospital in Amman, Jordan. It treats both adult and pediatric patients. KHCC treats over 3500 new cancer patients every year from Jordan and the region.

Ling Yuan "Thomas" Dao was a Chinese American physician and specialist in breast cancer, its causes and treatment, who was one of the earliest proponents of minimalist alternatives to radical mastectomy as a treatment option for breast cancer, in addition to advocacy of breast self-examination and mammography as means to detect breast cancer as early as possible.

S. Narasinga Rao is an American academic and former Dean of Jackson College of Graduate Studies and Research at the University of Central Oklahoma (1996–2006).

Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.

David Harker was an American medical researcher who according to The New York Times was "a pioneer in the use of X-rays to decipher the structure of critical substances in the life process of cells".

Mikhail Blagosklonny is a scientist who studies cancer and aging. He is an adjunct faculty member at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

<span class="mw-page-title-main">Economy of Buffalo, New York</span>

The Buffalo area economy consists of a mix of industrial, light manufacturing, high technology, and service-oriented private sector companies. Instead of relying on a single industry or sector for its economic future, the region has taken a diversified approach that has the potential to create opportunities for growth and expansion in the 21st century.

Keshav K. Singh is one of the global leaders in the field of mitochondria research and medicine. He is the Joy and Bill Harbert Endowed Chair, Professor of Genetics, Pathology and Environmental Health and the Director of the Cancer Genetics Program at the University of Alabama at Birmingham (UAB). Keshav K. Singh is also the founding editor-in-chief of the journal Mitochondrion., founder of the Mitochondria Research and Medicine Society (USA) and the Society for Mitochondrial Research and Medicine (India)

Michael A. Caligiuri, M.D. is a physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research, the world's largest cancer research organization, for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017), Director of the Comprehensive Cancer Center (2003-2017), and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.

Donald Lynn "Skip" Trump is an American oncologist who has been the executive director and chief executive officer of the Inova Schar Cancer Institute in Falls Church, Virginia, since January 2015. He has the same first and last name as former United States President Donald Trump, but they are not related to each other.

References

  1. "ABOUT HWI". hwi.buffalo.edu. Archived from the original on 22 December 2015. Retrieved 4 February 2016.
  2. Hauptman closer to breast cancer cure
  3. 1 2 3 4 "HWI History". hwi.buffalo.edu. Retrieved 4 February 2016.
  4. "News & Notes: Wilcove GS '85 wins Pioneer of Science Award". The Daily Princetonian . 29 November 2011.